Literature DB >> 17482429

Autoimmune cholangitis in NOD.c3c4 mice is associated with cholangiocyte-specific Fas antigen deficiency.

Yu Nakagome1, Yoshiyuki Ueno, Takayuki Kogure, Koji Fukushima, Yuki Moritoki, William M Ridgway, M Eric Gershwin, Tooru Shimosegawa.   

Abstract

A major handicap in understanding the pathogenesis of autoimmune cholangitis has been the absence of an informative mouse model. Recently, autoimmune cholangitis, with several features similar to PBC, has been described in NOD.c3c4 mice, including anti-mitochondrial antibodies, lymphocytic portal tract infiltrates, biliary destruction and the adoptive transfer of disease to naïve recipients using liver-derived lymphocytes. A unique feature, and a characteristic quite distinct from human PBC, is the presence of bile cyst formation. We have addressed the issue of cysts in NOD.c3c4 mice by performing comprehensive microarray analysis using cholangiocytes from NOD.c3c4 mice compared to NOD controls. Several key differences in gene expression were noted in NOD.c3c4 cholangiocytes. First, there was consistent impairment in the expression of Fas antigen (CD95). Second, cholangiocytes were PCNA positive but TUNEL negative, suggesting an absence of apoptosis despite abnormal proliferation. In conclusion, we propose that autoimmune cholangitis develops in NOD.c3c4 mice secondary to impaired biliary cell apoptosis with exposure of mitochondrial antigens, loss of tolerance and subsequent development of multi-lineage anti-mitochondrial responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482429     DOI: 10.1016/j.jaut.2007.03.004

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  13 in total

1.  Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.

Authors:  Guo-Xiang Yang; Zhe-Xiong Lian; Ya-Hui Chuang; Yuki Moritoki; Ruth Y Lan; Kanji Wakabayashi; Aftab A Ansari; Richard A Flavell; William M Ridgway; Ross L Coppel; Koichi Tsuneyama; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

2.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

3.  B cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis.

Authors:  Yuki Moritoki; Masanobu Tsuda; Koichi Tsuneyama; Weici Zhang; Katsunori Yoshida; Zhe-Xiong Lian; Guo-Xiang Yang; William M Ridgway; Linda S Wicker; Aftab A Ansari; M Eric Gershwin
Journal:  Cell Immunol       Date:  2011-01-28       Impact factor: 4.868

Review 4.  Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Lindsey Kennedy; Suthat Liangpunsakul; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2019-04-22       Impact factor: 6.902

Review 5.  Animal models of primary biliary cirrhosis.

Authors:  Tomohiro Katsumi; Kyoko Tomita; Patrick S C Leung; Guo-Xiang Yang; M Eric Gershwin; Yoshiyuki Ueno
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 6.  Animal models of primary biliary cirrhosis.

Authors:  Ya-Hui Chuang; William M Ridgway; Yoshiyuki Ueno; M Eric Gershwin
Journal:  Clin Liver Dis       Date:  2008-05       Impact factor: 6.126

Review 7.  Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Peter Fickert
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 8.  Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border.

Authors:  Ruth Y Lan; Ian R Mackay; M Eric Gershwin
Journal:  J Autoimmun       Date:  2007-09-21       Impact factor: 7.094

9.  Primary biliary cirrhosis is associated with altered hepatic microRNA expression.

Authors:  Kerstien A Padgett; Ruth Y Lan; Patrick C Leung; Ana Lleo; Kevin Dawson; Janice Pfeiff; Tin K Mao; Ross L Coppel; Aftab A Ansari; M Eric Gershwin
Journal:  J Autoimmun       Date:  2009-04-03       Impact factor: 7.094

Review 10.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.